Moderate To Severe Chronic Obstructive Pulmonary Disease
Phase III
Not Yet Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Jan 22, 2026
Itraconazole, Pf-07248144
Healthy Adult Participants
Phase I
Recruiting
A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)
Jan 05, 2026
Pf-07328948
Healthy, Renal Impairment
Phase I
Recruiting
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Dec 18, 2025
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pfizer (PFE) have in its pipeline
PFE is currently developing the following drugs: Tafamidis, Etrasimod, Pf-07328948. These drug candidates are in various stages of clinical development as the company works toward FDA approval.